These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 37833610)

  • 1. Global Antiphospholipid Syndrome Score (GAPSS) in Patients with Systemic Lupus Erythematosus.
    Cheldieva FA; Reshetnyak TM; Shumilova AA; Nurbaeva KS; Cherkasova MV; Lila AM; Nasonov EL
    Dokl Biochem Biophys; 2023 Aug; 511(1):227-234. PubMed ID: 37833610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombotic risk assessment in antiphospholipid syndrome: do noncriteria antibodies contribute?
    Uludağ Ö; Çinar S; McDonnell T; Çene E; Yalçinkaya Y; Gül A; Inanç M; Artim Esen B
    Turk J Med Sci; 2023; 53(5):1067-1074. PubMed ID: 38813003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the adjusted global antiphospholipid syndrome score in systemic lupus erythematosus patients in Argentina.
    Garcia L; Velloso MS; Martire MV; Savy F; Arizpe F; Garcia N; Testi A; Pena C; Costi AC; Isnardi C; Capelusnik D; Mazza S; Curi YS; Collado V; Rodriguez MF; Scarafia S; Pisoni C; de la Torre M; Seewald A; Riva ME; Garcia M
    Lupus; 2020 Dec; 29(14):1866-1872. PubMed ID: 33028177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GAPSS: the Global Anti-Phospholipid Syndrome Score.
    Sciascia S; Sanna G; Murru V; Roccatello D; Khamashta MA; Bertolaccini ML
    Rheumatology (Oxford); 2013 Aug; 52(8):1397-403. PubMed ID: 23315788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The global antiphospholipid syndrome score in women with systemic lupus erythematosus and adverse pregnancy outcomes.
    Schreiber K; Radin M; Cecchi I; Rubini E; Roccatello D; Jacobsen S; Cuadrado MJ; Sciascia S
    Clin Exp Rheumatol; 2021; 39(5):1071-1076. PubMed ID: 33200742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to Domain I β
    Reshetnyak TM; Cheldieva FA; Cherkasova MV; Glukhova SI; Lila AM; Nasonov EL
    Dokl Biochem Biophys; 2023 Aug; 511(1):219-226. PubMed ID: 37833609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregnancy success rate and response to heparins and/or aspirin differ in women with antiphospholipid antibodies according to their Global AntiphosPholipid Syndrome Score.
    Radin M; Cecchi I; Schreiber K; Rubini E; Roccatello D; Cuadrado MJ; Sciascia S
    Semin Arthritis Rheum; 2020 Jun; 50(3):553-556. PubMed ID: 32089355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of clinical and serological features in thrombotic antiphospholipid syndrome patients, with and without associated systemic lupus erythematosus, followed for up to 42 years: A single centre retrospective study.
    Mittal P; Pacheco M; Trives-Folguera L; Rua J; Tohidi-Esfahani I; Cohen H; Efthymiou M; Isenberg D
    Lupus; 2024 Sep; 33(10):1082-1088. PubMed ID: 39092568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombotic risk assessment in patients with systemic lupus erythematosus: Validation of the adjusted-Global Antiphospholipid Syndrome Score (aGAPSS) in Thai patients.
    Chanloung W; Kasitanon N; Wichainun R; Louthrenoo W
    Int J Rheum Dis; 2021 Dec; 24(12):1510-1519. PubMed ID: 34716670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superficial vein thrombosis, thrombin generation and activated protein C resistance as predictors of thromboembolic events in lupus and antiphospholipid patients. A prospective cohort study.
    Zuily S; Regnault V; Guillemin F; Kaminsky P; Rat AC; Lecompte T; Wahl D
    Thromb Res; 2013 Jul; 132(1):e1-7. PubMed ID: 23676348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombotic risk assessment in systemic lupus erythematosus: validation of the global antiphospholipid syndrome score in a prospective cohort.
    Sciascia S; Cuadrado MJ; Sanna G; Murru V; Roccatello D; Khamashta MA; Bertolaccini ML
    Arthritis Care Res (Hoboken); 2014 Dec; 66(12):1915-20. PubMed ID: 24964745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
    Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
    J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relevance of non-criteria antiphospholipid antibodies titers among patients with antiphospholipid syndrome and patients with systemic lupus erythematosus.
    Urrego-Callejas T; Hernández A; Ruiz Giraldo S; Frade-Sosa B; Vanegas-García AL; Muñoz CH; Rua C; Duque Botero J; González LA; Vásquez G; Gómez-Puerta JA
    Reumatol Clin (Engl Ed); 2023 Apr; 19(4):197-203. PubMed ID: 37061281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validity of the global anti-phospholipid syndrome score to predict thrombosis: a prospective multicentre cohort study.
    Zuily S; de Laat B; Mohamed S; Kelchtermans H; Shums Z; Albesa R; Norman GL; Lamboux-Matthieu C; Rat AC; Ninet J; Magy-Bertrand N; Pasquali JL; Lambert M; Lorcerie B; Kaminsky P; Guillemin F; Regnault V; Wahl D;
    Rheumatology (Oxford); 2015 Nov; 54(11):2071-5. PubMed ID: 26163690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profiling of non-criteria antiphospholipid antibodies in patients with SLE: differentiation of thrombotic SLE patients and risk of recurrence of thrombosis.
    Tkachenko O; Lapin S; Mazing A; Emanuel V; Belolipetskaia E; Beliaeva I; Myachikova V; Maslyansky A; Schierack P; Roggenbuck D
    Lupus; 2020 Apr; 29(5):490-498. PubMed ID: 32131675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated partial antiphospholipid score is a strong risk factor for thrombosis in patients with systemic lupus erythematosus: a validation study.
    Chen J; Sun S; Yan Q; Bao C; Fu Q
    Clin Rheumatol; 2016 Feb; 35(2):333-40. PubMed ID: 26753544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.
    İlgen U; Yayla ME; Ateş A; Okatan İE; Yurteri EU; Torgutalp M; Keleşoğlu ABD; Turgay TM; Kınıklı G
    Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the cardiovascular risk in patients with systemic lupus erythematosus: QRISK and GAPSS scores head-to-head.
    Barinotti A; Radin M; Cecchi I; Foddai SG; Arbrile M; Rubini E; Menegatti E; Roccatello D; Sciascia S
    Int J Cardiol; 2022 Sep; 363():185-189. PubMed ID: 35714714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the adjusted global antiphospholipid syndrome score in a single centre cohort of APS patients from Turkey.
    Uludağ Ö; Bektaş M; Çene E; Sezer M; Şahinkaya Y; Gül A; Inanç M; Öcal L; Artim-Esen B
    J Thromb Thrombolysis; 2021 Feb; 51(2):466-474. PubMed ID: 32588289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.